| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR8A1 CALCR TAPT1 OR1I1 OR10J6P OR10V1 OR10K1 OR52E1 MC5R OR8G5 ADGRV1 CALCRL OR7A17 OR56A1 GPR132 OR6M1 OR2AJ1 | 1.29e-07 | 884 | 84 | 17 | GO:0004930 |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR8A1 OR1I1 OR10J6P OR10V1 OR10K1 OR52E1 OR8G5 OR7A17 OR56A1 OR6M1 OR2AJ1 | 1.88e-06 | 431 | 84 | 11 | GO:0004984 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR8A1 BMPR1B CALCR TAPT1 OR1I1 OR10J6P OR10V1 OR10K1 OR52E1 MC5R OR8G5 ADGRV1 CALCRL OR7A17 OR56A1 GPR132 OR6M1 MUSK OR2AJ1 | 2.58e-06 | 1353 | 84 | 19 | GO:0004888 |
| GeneOntologyMolecularFunction | mannosyl-oligosaccharide mannosidase activity | 8.44e-06 | 10 | 84 | 3 | GO:0015924 | |
| GeneOntologyMolecularFunction | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity | 1.75e-05 | 2 | 84 | 2 | GO:0004572 | |
| GeneOntologyMolecularFunction | calcitonin receptor activity | 1.75e-05 | 2 | 84 | 2 | GO:0004948 | |
| GeneOntologyMolecularFunction | alpha-mannosidase activity | 3.15e-05 | 15 | 84 | 3 | GO:0004559 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 3.24e-05 | 144 | 84 | 6 | GO:0016798 | |
| GeneOntologyMolecularFunction | mannosidase activity | 3.87e-05 | 16 | 84 | 3 | GO:0015923 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 7.40e-05 | 103 | 84 | 5 | GO:0004553 | |
| GeneOntologyMolecularFunction | calcitonin family binding | 1.04e-04 | 4 | 84 | 2 | GO:0097644 | |
| GeneOntologyMolecularFunction | calcitonin gene-related peptide receptor activity | 1.04e-04 | 4 | 84 | 2 | GO:0001635 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 1.04e-04 | 4 | 84 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 1.07e-04 | 446 | 84 | 9 | GO:0004674 | |
| GeneOntologyMolecularFunction | protein kinase activity | 2.08e-04 | 600 | 84 | 10 | GO:0004672 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 2.59e-04 | 6 | 84 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | kinase activity | PRKAG3 BMPR1B CDK13 ADCK1 MAGI3 AKT2 PRKCQ ULK2 PLK4 MUSK NEK11 | 3.49e-04 | 764 | 84 | 11 | GO:0016301 |
| GeneOntologyMolecularFunction | calcitonin family receptor activity | 3.62e-04 | 7 | 84 | 2 | GO:0097642 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing N-glycosyl compounds | 6.82e-04 | 41 | 84 | 3 | GO:0016799 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 7.72e-04 | 709 | 84 | 10 | GO:0016773 | |
| GeneOntologyMolecularFunction | hormone binding | 9.39e-04 | 103 | 84 | 4 | GO:0042562 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | PRKAG3 BMPR1B CDK13 ADCK1 MAGI3 AKT2 PRKCQ ULK2 PLK4 MUSK NEK11 | 1.87e-03 | 938 | 84 | 11 | GO:0016772 |
| GeneOntologyMolecularFunction | odorant binding | 2.03e-03 | 127 | 84 | 4 | GO:0005549 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 2.56e-03 | 18 | 84 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 3.44e-03 | 465 | 84 | 7 | GO:0046873 | |
| GeneOntologyMolecularFunction | sialyltransferase activity | 3.49e-03 | 21 | 84 | 2 | GO:0008373 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 4.28e-03 | 363 | 84 | 6 | GO:0106310 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 4.85e-03 | 627 | 84 | 8 | GO:0022890 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 5.32e-03 | 26 | 84 | 2 | GO:0005248 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 6.79e-03 | 664 | 84 | 8 | GO:0008324 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR8A1 OR1I1 OR10J6P OR10V1 OR10K1 OR52E1 OR8G5 OR7A17 OR56A1 OR6M1 RYR2 OR2AJ1 | 1.77e-06 | 524 | 86 | 12 | GO:0009593 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR8A1 OR1I1 OR10J6P OR10V1 OR10K1 OR52E1 OR8G5 OR7A17 OR56A1 OR6M1 OR2AJ1 | 1.79e-06 | 432 | 86 | 11 | GO:0050911 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR8A1 OR1I1 OR10J6P OR10V1 OR10K1 OR52E1 OR8G5 OR7A17 OR56A1 OR6M1 OR2AJ1 | 3.63e-06 | 465 | 86 | 11 | GO:0007608 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR8A1 OR1I1 OR10J6P OR10V1 OR10K1 OR52E1 OR8G5 ADGRV1 OR7A17 OR56A1 OR6M1 OR2AJ1 | 5.19e-06 | 582 | 86 | 12 | GO:0050906 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR8A1 OR1I1 OR10J6P OR10V1 OR10K1 OR52E1 OR8G5 OR7A17 OR56A1 OR6M1 OR2AJ1 | 5.42e-06 | 485 | 86 | 11 | GO:0050907 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR8A1 OR1I1 OR10J6P OR10V1 OR10K1 OR52E1 OR8G5 ADGRV1 OR7A17 OR56A1 OR6M1 RYR2 OR2AJ1 | 8.79e-06 | 722 | 86 | 13 | GO:0051606 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR8A1 CALCR TAPT1 OR1I1 PLPP1 OR10J6P OR10V1 OR10K1 OR52E1 MC5R OR8G5 ADGRV1 CALCRL OR7A17 OR56A1 GPR132 OR6M1 OR2AJ1 | 1.45e-05 | 1395 | 86 | 18 | GO:0007186 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR8A1 OR1I1 OR10J6P OR10V1 OR10K1 OR52E1 OR8G5 OR7A17 OR56A1 OR6M1 OR2AJ1 | 1.67e-05 | 547 | 86 | 11 | GO:0007606 |
| GeneOntologyBiologicalProcess | sensory perception | OR8A1 OR1I1 MYO7A MYO7B OR10J6P OR10V1 OR10K1 OR52E1 SLC45A2 OR8G5 ADGRV1 OR7A17 OR56A1 OR6M1 OR2AJ1 | 3.35e-05 | 1072 | 86 | 15 | GO:0007600 |
| GeneOntologyBiologicalProcess | protein deglycosylation | 5.46e-05 | 18 | 86 | 3 | GO:0006517 | |
| GeneOntologyBiologicalProcess | maintenance of animal organ identity | 1.70e-04 | 5 | 86 | 2 | GO:0048496 | |
| GeneOntologyCellularComponent | calcitonin family receptor complex | 1.62e-04 | 5 | 85 | 2 | GO:1903439 | |
| MousePheno | absent cochlear hair bundle ankle links | 1.81e-05 | 2 | 60 | 2 | MP:0004582 | |
| MousePheno | abnormal cochlear hair bundle ankle links morphology | 1.81e-05 | 2 | 60 | 2 | MP:0004581 | |
| Domain | MIR | 1.03e-05 | 10 | 84 | 3 | PS50919 | |
| Domain | MIR | 1.03e-05 | 10 | 84 | 3 | PF02815 | |
| Domain | MIR | 1.03e-05 | 10 | 84 | 3 | SM00472 | |
| Domain | MIR_motif | 1.03e-05 | 10 | 84 | 3 | IPR016093 | |
| Domain | GCPR_2_calcitonin_rcpt_fam | 2.00e-05 | 2 | 84 | 2 | IPR003287 | |
| Domain | - | 3.08e-05 | 14 | 84 | 3 | 2.60.40.1180 | |
| Domain | Glyco_hydro_b | 3.84e-05 | 15 | 84 | 3 | IPR013780 | |
| Domain | Ryanrecept_TM4-6 | 5.98e-05 | 3 | 84 | 2 | IPR009460 | |
| Domain | RyR | 5.98e-05 | 3 | 84 | 2 | PF02026 | |
| Domain | Ryanodine_rcpt | 5.98e-05 | 3 | 84 | 2 | IPR003032 | |
| Domain | RR_TM4-6 | 5.98e-05 | 3 | 84 | 2 | PF06459 | |
| Domain | Ryan_recept | 5.98e-05 | 3 | 84 | 2 | IPR013333 | |
| Domain | Olfact_rcpt | 6.75e-05 | 393 | 84 | 9 | IPR000725 | |
| Domain | - | 1.98e-04 | 5 | 84 | 2 | 1.20.1270.50 | |
| Domain | - | 1.98e-04 | 5 | 84 | 2 | 3.20.110.10 | |
| Domain | Glyco_hydro_38_C | 1.98e-04 | 5 | 84 | 2 | IPR011682 | |
| Domain | Alpha-mann_mid | 1.98e-04 | 5 | 84 | 2 | SM00872 | |
| Domain | Alpha-mann_mid | 1.98e-04 | 5 | 84 | 2 | PF09261 | |
| Domain | Glyco_hydro_38_N | 1.98e-04 | 5 | 84 | 2 | IPR000602 | |
| Domain | Glyco_hydro_38/57_N | 1.98e-04 | 5 | 84 | 2 | IPR027291 | |
| Domain | Glyco_hydro_38_cen | 1.98e-04 | 5 | 84 | 2 | IPR015341 | |
| Domain | Glyco_hydro_57/38_cen | 1.98e-04 | 5 | 84 | 2 | IPR028995 | |
| Domain | Glyco_hydro_38C | 1.98e-04 | 5 | 84 | 2 | PF07748 | |
| Domain | Glyco_hydro_38 | 1.98e-04 | 5 | 84 | 2 | PF01074 | |
| Domain | PROTEIN_KINASE_ATP | 2.18e-04 | 459 | 84 | 9 | PS00107 | |
| Domain | 7tm_1 | OR8A1 OR1I1 OR10V1 OR10K1 MC5R OR8G5 OR7A17 OR56A1 GPR132 OR6M1 OR2AJ1 | 2.19e-04 | 677 | 84 | 11 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR8A1 OR1I1 OR10V1 OR10K1 MC5R OR8G5 OR7A17 OR56A1 GPR132 OR6M1 OR2AJ1 | 2.43e-04 | 685 | 84 | 11 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR8A1 OR1I1 OR10V1 OR10K1 MC5R OR8G5 OR7A17 OR56A1 GPR132 OR6M1 OR2AJ1 | 2.61e-04 | 691 | 84 | 11 | PS50262 |
| Domain | GPCR_Rhodpsn | OR8A1 OR1I1 OR10V1 OR10K1 MC5R OR8G5 OR7A17 OR56A1 GPR132 OR6M1 OR2AJ1 | 2.65e-04 | 692 | 84 | 11 | IPR000276 |
| Domain | RIH_assoc | 2.96e-04 | 6 | 84 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 2.96e-04 | 6 | 84 | 2 | IPR013662 | |
| Domain | RIH_dom | 2.96e-04 | 6 | 84 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 2.96e-04 | 6 | 84 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 2.96e-04 | 6 | 84 | 2 | IPR015925 | |
| Domain | - | 2.96e-04 | 6 | 84 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 2.96e-04 | 6 | 84 | 2 | PF01365 | |
| Domain | Ins145_P3_rec | 2.96e-04 | 6 | 84 | 2 | PF08709 | |
| Domain | Prot_kinase_dom | 3.47e-04 | 489 | 84 | 9 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 3.68e-04 | 493 | 84 | 9 | PS50011 | |
| Domain | Glyco_hydro/deAcase_b/a-brl | 4.14e-04 | 7 | 84 | 2 | IPR011330 | |
| Domain | MYTH4 | 7.05e-04 | 9 | 84 | 2 | PS51016 | |
| Domain | MyTH4_dom | 7.05e-04 | 9 | 84 | 2 | IPR000857 | |
| Domain | MyTH4 | 7.05e-04 | 9 | 84 | 2 | PF00784 | |
| Domain | MyTH4 | 7.05e-04 | 9 | 84 | 2 | SM00139 | |
| Domain | Kinase-like_dom | 7.28e-04 | 542 | 84 | 9 | IPR011009 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 7.69e-04 | 40 | 84 | 3 | PS00649 | |
| Domain | GPCR_2_extracellular_dom | 7.69e-04 | 40 | 84 | 3 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 7.69e-04 | 40 | 84 | 3 | PS50227 | |
| Domain | GPCR_Rhodpsn_7TM | OR8A1 OR1I1 OR10V1 OR10K1 MC5R OR8G5 OR7A17 OR56A1 GPR132 OR6M1 | 8.33e-04 | 670 | 84 | 10 | IPR017452 |
| Domain | 6PGD_dom_2 | 8.79e-04 | 10 | 84 | 2 | IPR013328 | |
| Domain | - | 8.79e-04 | 10 | 84 | 2 | 1.10.1040.10 | |
| Domain | S_TKc | 1.17e-03 | 359 | 84 | 7 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 1.22e-03 | 362 | 84 | 7 | PS00108 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 1.48e-03 | 50 | 84 | 3 | PS00650 | |
| Domain | 7tm_2 | 1.48e-03 | 50 | 84 | 3 | PF00002 | |
| Domain | Protein_kinase_ATP_BS | 1.59e-03 | 379 | 84 | 7 | IPR017441 | |
| Domain | Pkinase | 1.64e-03 | 381 | 84 | 7 | PF00069 | |
| Domain | Ion_trans_dom | 1.74e-03 | 114 | 84 | 4 | IPR005821 | |
| Domain | Ion_trans | 1.74e-03 | 114 | 84 | 4 | PF00520 | |
| Domain | GPCR_2_secretin-like | 2.50e-03 | 60 | 84 | 3 | IPR000832 | |
| Domain | GPCR_2-like | 2.50e-03 | 60 | 84 | 3 | IPR017981 | |
| Domain | Gal_mutarotase_SF_dom | 2.60e-03 | 17 | 84 | 2 | IPR011013 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 2.62e-03 | 61 | 84 | 3 | PS50261 | |
| Domain | 6-PGluconate_DH_C-like | 3.25e-03 | 19 | 84 | 2 | IPR008927 | |
| Domain | Glyco_trans_29 | 3.60e-03 | 20 | 84 | 2 | IPR001675 | |
| Domain | Glyco_transf_29 | 3.60e-03 | 20 | 84 | 2 | PF00777 | |
| Domain | IQ | 4.02e-03 | 71 | 84 | 3 | PF00612 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR8A1 OR1I1 MYO7A SCN3A OR10V1 OR10K1 OR52E1 PRKCQ OR8G5 OR7A17 OR56A1 OR6M1 OR2AJ1 | 1.06e-05 | 636 | 69 | 13 | M41834 |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR8A1 OR1I1 OR10V1 OR10K1 OR52E1 OR8G5 OR7A17 OR56A1 OR6M1 OR2AJ1 | 3.29e-05 | 417 | 69 | 10 | M4072 |
| Pubmed | Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos. | 2.90e-07 | 6 | 86 | 3 | 26025922 | |
| Pubmed | Appl1 is dispensable for Akt signaling in vivo and mouse T-cell development. | 3.16e-06 | 12 | 86 | 3 | 20665729 | |
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 3.97e-06 | 168 | 86 | 6 | 30631154 | |
| Pubmed | USP38 critically promotes asthmatic pathogenesis by stabilizing JunB protein. | 6.04e-06 | 2 | 86 | 2 | 30224386 | |
| Pubmed | Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease. | 6.04e-06 | 2 | 86 | 2 | 21531043 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 16678258 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 19903822 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 8898078 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 8524845 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 14550562 | ||
| Pubmed | N-Glycan structure analysis using lectins and an alpha-mannosidase activity assay. | 6.04e-06 | 2 | 86 | 2 | 17113875 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 14985349 | ||
| Pubmed | Germ cell survival through carbohydrate-mediated interaction with Sertoli cells. | 6.04e-06 | 2 | 86 | 2 | 11778047 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 16754854 | ||
| Pubmed | OR8A1 OR10J6P OR10V1 OR10K1 OR8G5 OR7A17 OR56A1 OR6M1 OR2AJ1 | 7.93e-06 | 541 | 86 | 9 | 14983052 | |
| Pubmed | DEFOG: a practical scheme for deciphering families of genes. | 1.80e-05 | 219 | 86 | 6 | 12213199 | |
| Pubmed | Deltex1 promotes protein kinase Cθ degradation and sustains Casitas B-lineage lymphoma expression. | 1.81e-05 | 3 | 86 | 2 | 25000980 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 18403125 | ||
| Pubmed | Deficiency of RAMP1 attenuates antigen-induced airway hyperresponsiveness in mice. | 1.81e-05 | 3 | 86 | 2 | 25010197 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 18434746 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 32382040 | ||
| Pubmed | Control of Neuronal Ryanodine Receptor-Mediated Calcium Signaling by Calsenilin. | 1.81e-05 | 3 | 86 | 2 | 29730765 | |
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 1.81e-05 | 3 | 86 | 2 | 9204703 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 7876312 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 21881589 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 18384073 | ||
| Pubmed | Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). | 1.81e-05 | 3 | 86 | 2 | 12213830 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 9242641 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 22948152 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 29142287 | ||
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 1.81e-05 | 3 | 86 | 2 | 10788707 | |
| Pubmed | RYR2 proteins contribute to the formation of Ca(2+) sparks in smooth muscle. | 1.81e-05 | 3 | 86 | 2 | 15024040 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 15070827 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 25239916 | ||
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 1.81e-05 | 3 | 86 | 2 | 7621815 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 18643873 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 11159936 | ||
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 1.81e-05 | 3 | 86 | 2 | 10473538 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 7959768 | ||
| Pubmed | The organization of proteins in the human red blood cell membrane. A review. | 1.81e-05 | 3 | 86 | 2 | 4600883 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 7635066 | ||
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | 2.22e-05 | 340 | 86 | 7 | 11875048 | |
| Pubmed | 2.22e-05 | 340 | 86 | 7 | 11802173 | ||
| Pubmed | 2.35e-05 | 343 | 86 | 7 | 32295537 | ||
| Pubmed | 2.49e-05 | 346 | 86 | 7 | 14611657 | ||
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 18206662 | ||
| Pubmed | Impact of air pollution and genotype variability on DNA damage in Prague policemen. | 3.61e-05 | 4 | 86 | 2 | 17590289 | |
| Pubmed | The TSC-mTOR signaling pathway regulates the innate inflammatory response. | 3.61e-05 | 4 | 86 | 2 | 18848473 | |
| Pubmed | Usher syndromes due to MYO7A, PCDH15, USH2A or GPR98 mutations share retinal disease mechanism. | 3.61e-05 | 4 | 86 | 2 | 18463160 | |
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 3.61e-05 | 4 | 86 | 2 | 23413940 | |
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 9384575 | ||
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 21291857 | ||
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 9607712 | ||
| Pubmed | Supernumerary centrosomes nucleate extra cilia and compromise primary cilium signaling. | 3.61e-05 | 4 | 86 | 2 | 22840514 | |
| Pubmed | Homotypic and heterotypic adhesion induced by odorant receptors and the β2-adrenergic receptor. | 3.61e-05 | 4 | 86 | 2 | 24312457 | |
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 23482488 | ||
| Pubmed | Modulation of the combinatorial code of odorant receptor response patterns in odorant mixtures. | 4.09e-05 | 27 | 86 | 3 | 32061665 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | ATRN CRYL1 MAN2A1 SLC12A3 PLPP1 GBE1 APPL1 SERINC2 ADGRV1 PGD SERPINA7 | 4.15e-05 | 1016 | 86 | 11 | 19056867 |
| Pubmed | 6.01e-05 | 5 | 86 | 2 | 33060591 | ||
| Pubmed | APPL1, APPL2, Akt2 and FOXO1a interact with FSHR in a potential signaling complex. | 6.01e-05 | 5 | 86 | 2 | 17030088 | |
| Pubmed | 6.01e-05 | 5 | 86 | 2 | 23918386 | ||
| Pubmed | 6.01e-05 | 5 | 86 | 2 | 10490823 | ||
| Pubmed | 6.01e-05 | 5 | 86 | 2 | 36640312 | ||
| Pubmed | Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells. | 6.01e-05 | 5 | 86 | 2 | 19011160 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | JUNB NADSYN1 MAN2A2 KIAA0513 MYO7A CDK13 AKT2 TSC2 IDUA ULK2 TBC1D17 | 8.79e-05 | 1105 | 86 | 11 | 35748872 |
| Pubmed | 9.01e-05 | 6 | 86 | 2 | 19549818 | ||
| Pubmed | 9.01e-05 | 6 | 86 | 2 | 23463619 | ||
| Pubmed | FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells. | 9.01e-05 | 6 | 86 | 2 | 14592808 | |
| Pubmed | 9.01e-05 | 6 | 86 | 2 | 20519450 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 9.01e-05 | 6 | 86 | 2 | 25966694 | |
| Pubmed | 9.01e-05 | 6 | 86 | 2 | 15314020 | ||
| Pubmed | 9.01e-05 | 6 | 86 | 2 | 19009018 | ||
| Pubmed | Protein kinase B alpha/Akt1 regulates placental development and fetal growth. | 9.01e-05 | 6 | 86 | 2 | 12783884 | |
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 9.01e-05 | 6 | 86 | 2 | 16844763 | |
| Pubmed | Reciprocal signalling by Notch-Collagen V-CALCR retains muscle stem cells in their niche. | 1.26e-04 | 7 | 86 | 2 | 29795344 | |
| Pubmed | 1.26e-04 | 7 | 86 | 2 | 11212352 | ||
| Pubmed | 1.26e-04 | 7 | 86 | 2 | 14722252 | ||
| Pubmed | 1.26e-04 | 7 | 86 | 2 | 10882736 | ||
| Pubmed | 1.26e-04 | 7 | 86 | 2 | 11860456 | ||
| Pubmed | Deletion of skeletal muscle Akt1/2 causes osteosarcopenia and reduces lifespan in mice. | 1.26e-04 | 7 | 86 | 2 | 36198696 | |
| Pubmed | 1.26e-04 | 7 | 86 | 2 | 20962236 | ||
| Pubmed | 1.68e-04 | 8 | 86 | 2 | 20040596 | ||
| Pubmed | Microarray-based mutation analysis of 183 Spanish families with Usher syndrome. | 1.68e-04 | 8 | 86 | 2 | 19683999 | |
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 1.68e-04 | 8 | 86 | 2 | 19033399 | |
| Pubmed | 1.68e-04 | 8 | 86 | 2 | 21441923 | ||
| Pubmed | 1.68e-04 | 8 | 86 | 2 | 11784029 | ||
| Pubmed | 1.68e-04 | 8 | 86 | 2 | 19384953 | ||
| Pubmed | TSC2 mediates cellular energy response to control cell growth and survival. | 2.15e-04 | 9 | 86 | 2 | 14651849 | |
| Pubmed | Massively parallel DNA sequencing facilitates diagnosis of patients with Usher syndrome type 1. | 2.68e-04 | 10 | 86 | 2 | 24618850 | |
| Pubmed | 2.68e-04 | 10 | 86 | 2 | 24239741 | ||
| Pubmed | HIV-1 gp120 N-linked glycosylation differs between plasma and leukocyte compartments. | 2.68e-04 | 10 | 86 | 2 | 18215327 | |
| Pubmed | 2.68e-04 | 10 | 86 | 2 | 18330979 | ||
| Pubmed | 2.68e-04 | 10 | 86 | 2 | 17329413 | ||
| Pubmed | 2.68e-04 | 10 | 86 | 2 | 18314154 | ||
| Pubmed | Non-proteolytic ubiquitination of OTULIN regulates NF-κB signaling pathway. | 3.28e-04 | 11 | 86 | 2 | 31504727 | |
| Pubmed | 3.28e-04 | 11 | 86 | 2 | 27402918 | ||
| Pubmed | Opposite effects of HIV-1 p17 variants on PTEN activation and cell growth in B cells. | 3.28e-04 | 11 | 86 | 2 | 21423810 | |
| Pubmed | The chromosomal distribution of mouse odorant receptor genes. | 3.31e-04 | 54 | 86 | 3 | 8570653 | |
| Pubmed | 3.93e-04 | 12 | 86 | 2 | 23275438 | ||
| Pubmed | 3.93e-04 | 12 | 86 | 2 | 19095005 | ||
| GeneFamily | Calcitonin receptors | 1.12e-05 | 2 | 61 | 2 | 265 | |
| GeneFamily | A-kinase anchoring proteins|Myosins, class VII|Deafness associated genes|FERM domain containing | 1.12e-05 | 2 | 61 | 2 | 1102 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 3.35e-05 | 3 | 61 | 2 | 287 | |
| GeneFamily | Mannosidases alpha class 2 | 1.11e-04 | 5 | 61 | 2 | 1194 | |
| GeneFamily | Olfactory receptors, family 10 | 1.44e-03 | 66 | 61 | 3 | 157 | |
| GeneFamily | Sialyltransferases | 2.05e-03 | 20 | 61 | 2 | 438 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.65e-06 | 186 | 86 | 6 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-23|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.70e-06 | 187 | 86 | 6 | 69b47f00598d647e2a99427ebddf42c339428e47 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.86e-06 | 190 | 86 | 6 | 6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.04e-06 | 193 | 86 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-05 | 160 | 86 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-05 | 160 | 86 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.57e-05 | 162 | 86 | 5 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 169 | 86 | 5 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-05 | 173 | 86 | 5 | 9dc7746a84f0e268a7c061e1bbcd5e31903034dc | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.15e-05 | 173 | 86 | 5 | 7dc988fc0ba29990567bf1bcdeb3faeeee507eb1 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l9|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.15e-05 | 173 | 86 | 5 | da0f1461643294f92e20b5e456a50211a2780a91 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-05 | 175 | 86 | 5 | f6e1d7297a4dbb38e1ab4f738d91f0e62abaee69 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 2.67e-05 | 181 | 86 | 5 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-05 | 183 | 86 | 5 | 919c9861073d12fd12aecd7469b1478b13838c43 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.96e-05 | 185 | 86 | 5 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.04e-05 | 186 | 86 | 5 | 9579180db2a0bf3f043b4d169f9a08cdc45b459a | |
| ToppCell | CF|World / Disease state, Lineage and Cell class | 3.12e-05 | 187 | 86 | 5 | eec4d4e4a658e3a61c05745167a1a5e3d39bb43e | |
| ToppCell | Endothelial-endothelial_cell_of_lymph_vessel|World / Lineage, Cell type, age group and donor | 3.20e-05 | 188 | 86 | 5 | 80910dcbb51990f2baed240f319456c0d3fa2065 | |
| ToppCell | Endothelial-B|World / lung cells shred on cell class, cell subclass, sample id | 3.20e-05 | 188 | 86 | 5 | 5959a88728812a5f4cbfa54eddc7a73ccbaa2f68 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.20e-05 | 188 | 86 | 5 | aeecbc057dc823f8fcea8a98f18d213bacc7f4db | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.28e-05 | 189 | 86 | 5 | 55a1776a4ce049959b3f13a43744c7314bc1f00a | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.36e-05 | 190 | 86 | 5 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.36e-05 | 190 | 86 | 5 | a7498fe55b7810c482291db782dc5282675d246a | |
| ToppCell | IPF-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class | 3.36e-05 | 190 | 86 | 5 | ac029e73da5995221c9b9af551d85e4b835e21d6 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Granulocytic|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.45e-05 | 191 | 86 | 5 | 78ede1f15484414a2a54a2f0f0cb6abe0c6b6513 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-05 | 191 | 86 | 5 | 4fcbc214853e115608b3be7b35639247ae41c9dc | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Granulocytic-Neutrophil|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.45e-05 | 191 | 86 | 5 | d049ab9abd5f8d497eb7e3ccb39b28283298bc65 | |
| ToppCell | IPF-Endothelial-Lymphatic|IPF / Disease state, Lineage and Cell class | 3.54e-05 | 192 | 86 | 5 | 2496edd8f3a41146d418879de9ee2ccc7857431f | |
| ToppCell | 3'-Distal_airway-Endothelial-Lymphatic_EC|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.54e-05 | 192 | 86 | 5 | 2ec132a1740e865e7cc0f82ffd4772d43f7ac086 | |
| ToppCell | 3'-Distal_airway-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.54e-05 | 192 | 86 | 5 | 3792c53b5d4b759573e1c7bb89ef9b654c9cbfcd | |
| ToppCell | 3'-Distal_airway-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.54e-05 | 192 | 86 | 5 | 64022a47dccd7966777f6741d1c68e298f37ca9d | |
| ToppCell | 3'-Distal_airway-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature-Lymphatic_EC_mature_L.2.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.54e-05 | 192 | 86 | 5 | f67a88bd039944d3d7a5a4a9f2e053985075155c | |
| ToppCell | COPD-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class | 3.62e-05 | 193 | 86 | 5 | 25bdc557055b5bce6a21f8696b48e991c696b979 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.62e-05 | 193 | 86 | 5 | 040f6bb42aa41d0921371fdda1cc0912c4fe1930 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.62e-05 | 193 | 86 | 5 | e468287c8b30c56d1de65e8347ade233ba6cf584 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-05 | 193 | 86 | 5 | 1aa3ab528605dc7b2fec46e759c9d1ee93d59b11 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.71e-05 | 194 | 86 | 5 | 937ee85ffd50869b60f0f6e91017ab77e8b24c0b | |
| ToppCell | severe-Myeloid-Neutrophils_3|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.71e-05 | 194 | 86 | 5 | 1f8edab1c8ba48bc0114429ea47aab378b5830b7 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.00e-05 | 197 | 86 | 5 | 407231542fa1ffd540dcb61435c0575e71f59725 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-05 | 197 | 86 | 5 | e5ab45cfe4ebd02ca25029d87bece70dfbb4adc4 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.09e-05 | 198 | 86 | 5 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.09e-05 | 198 | 86 | 5 | 5d42f4fda2081ea3e9f62a00e7eea702e0d0be7d | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.09e-05 | 198 | 86 | 5 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.09e-05 | 198 | 86 | 5 | 99d6a64f3410dae3019161feef20a8f06081a24b | |
| ToppCell | Biopsy_IPF-Endothelial-Lymphatic_Endothelial_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 4.19e-05 | 199 | 86 | 5 | 483b01f1308eb201a1ff3788fe656c486b6b9e66 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.29e-05 | 200 | 86 | 5 | c59f262b2b0a7e7dcb2940d1e466f98db6c56625 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.29e-05 | 200 | 86 | 5 | e50ef394e3284a8323bfd60575b262b2be422aea | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-T-T_CD8-gdT|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.48e-04 | 138 | 86 | 4 | 769be787e24532d5e023f99f82c7272bddac40c3 | |
| ToppCell | IIH-CD4-CD8_1|IIH / Condition, Cell_class and T cell subcluster | 1.79e-04 | 145 | 86 | 4 | 296b6b0eea3233d76742ea35252b2f54d4c27ab6 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.84e-04 | 146 | 86 | 4 | 447c05414eda71681a0c07baba900f88ed6165ed | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-B_lymphocytic-naive_B_cell|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.09e-04 | 151 | 86 | 4 | 0f8f07e44c6edaf09574930b416fdce14d67095a | |
| ToppCell | COVID-19-Heart-Adipocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.20e-04 | 153 | 86 | 4 | 93958bd9c951222ba5b740d1cb83fd5d78a10e1e | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-04 | 154 | 86 | 4 | 37765512dfae557b9f6eb30a29463b93682a4404 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-2|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.31e-04 | 155 | 86 | 4 | 0fd66c623cb433ceaa893bc21ba2e3b394faaf70 | |
| ToppCell | (08)_PNEC-(4)_1wkpi|(08)_PNEC / shred by cell type and Timepoint | 2.35e-04 | 12 | 86 | 2 | f1b105bcdbe03be6765c820b42c752a24d502212 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-04 | 157 | 86 | 4 | 9021900d9b1a71210c9c414a9d165eaf399eb607 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-04 | 157 | 86 | 4 | c8c627ca181856cd31dba4cf073c2be659a49dc1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-04 | 159 | 86 | 4 | fd7db2f7328cfefdc3ada2af91006d5a91d137e1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-04 | 159 | 86 | 4 | aaf449c768d6fbb0a1bb47746ff3bdb7f9eb8914 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.55e-04 | 159 | 86 | 4 | 8680b054622f573a82b1625fb93c2d5db81d1034 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-04 | 159 | 86 | 4 | 8bbdef1e927f3130b578d7d7c5ff38bbe06fab63 | |
| ToppCell | Influenza_Severe-Neutrophil|Influenza_Severe / Disease group and Cell class | 2.67e-04 | 161 | 86 | 4 | 98c95b1b85d5427415af2ca8fb14849e97f6e8b5 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.00e-04 | 166 | 86 | 4 | c20479fe7a4306320d7f26e78bf956225f00f35a | |
| ToppCell | Endothelial-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 3.07e-04 | 167 | 86 | 4 | 6a03d16165e0b003092c39972928981abd4a75aa | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-7|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 3.07e-04 | 167 | 86 | 4 | 01c42e555913b17e62846325cc17b3d8f92da1e1 | |
| ToppCell | Influenza_Severe-Neutrophil|World / Disease group and Cell class | 3.21e-04 | 169 | 86 | 4 | 6e8e2580e19c96bcf7fa6a6d8c183df65f428396 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 3.28e-04 | 170 | 86 | 4 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 3.28e-04 | 170 | 86 | 4 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.28e-04 | 170 | 86 | 4 | bda900c836e0f2c1d7b442beb50b672d025b2420 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-ABC_aged-B_naive|bone_marrow / Manually curated celltypes from each tissue | 3.36e-04 | 171 | 86 | 4 | fcc31a9a69f96de10d1324a5a4fbfe4289bf4984 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.36e-04 | 171 | 86 | 4 | 3d26ef58fe5231373d7df9ac79d225546918cf82 | |
| ToppCell | Endothelial-B-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 3.36e-04 | 171 | 86 | 4 | 07ff7059071da83da1d8f266a586573920d75b58 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_THEMIS_PLA2G7|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.43e-04 | 172 | 86 | 4 | 1d086e00cd549459d70e1d3b468d5ab6379f3bee | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 3.51e-04 | 173 | 86 | 4 | 42c911ed16fabdabef063830e8407192d8bde950 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122|Adult / Lineage, Cell type, age group and donor | 3.51e-04 | 173 | 86 | 4 | dba09ba9748871e38a16449d500ae4d7b405c42f | |
| ToppCell | LV-17._Lymphocyte|World / Chamber and Cluster_Paper | 3.51e-04 | 173 | 86 | 4 | 212f013ff761cbab24a537071739867c08c402a4 | |
| ToppCell | severe_influenza-Neutrophil|severe_influenza / disease group, cell group and cell class (v2) | 3.51e-04 | 173 | 86 | 4 | 615e266419b9f06e964eff73cb466f05451ba0dd | |
| ToppCell | facs-MAT-Fat-18m-Lymphocytic-T_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-04 | 173 | 86 | 4 | 97391a763c17ce0107c9e2386e88c417ac75a72e | |
| ToppCell | Endothelial-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 3.51e-04 | 173 | 86 | 4 | a81992965137195d20fc498f750975303961a828 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.58e-04 | 174 | 86 | 4 | 7c8cc5c2872fc7bcca7ebddaf5a6f20e617a2674 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-04 | 175 | 86 | 4 | a72c6ceca5ddbd34f652e7302defefa2d105e17e | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-basophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.66e-04 | 175 | 86 | 4 | ba1befc4e5f0167452f9ceace39377d16136dfa9 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-CD8+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-04 | 175 | 86 | 4 | 9a462e9e6f7bbb64abb09ad6c080df3576073540 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-04 | 176 | 86 | 4 | c6484334187f64cd00cd35e77d8ae436556b4260 | |
| ToppCell | droplet-Fat-Mat-18m-Hematologic-monocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-04 | 176 | 86 | 4 | 867936a20f73f638055c19c8d88834aa2cc657cf | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.74e-04 | 176 | 86 | 4 | 6b1cf1e98b4509e87f9eea827fa7090ce1e504f1 | |
| ToppCell | Control-Neuronal_cells-Neuronal_cells|Control / group, cell type (main and fine annotations) | 3.74e-04 | 176 | 86 | 4 | 98c07d26ba0dc0fe15ca0ea81f633d4591782bd1 | |
| ToppCell | Control-Neuronal_cells|Control / group, cell type (main and fine annotations) | 3.74e-04 | 176 | 86 | 4 | c29d09ecf0eb17f767d78af4b7f2e7725c967ff8 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.74e-04 | 176 | 86 | 4 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-04 | 177 | 86 | 4 | 065bebd22031f143e90a407f952b444a3f8818c7 | |
| ToppCell | COVID-19-Heart-Lymph_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.82e-04 | 177 | 86 | 4 | 326fde0734ef0d7272693966d346ca479b9d8147 | |
| ToppCell | facs-Marrow-Granulocytes-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-04 | 177 | 86 | 4 | eb304f20aab075bd17aa3aef819386c0e1a235bd | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.91e-04 | 178 | 86 | 4 | 5289ac61637224ae70ffbc2d164d73116f10af40 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231|Adult / Lineage, Cell type, age group and donor | 3.91e-04 | 178 | 86 | 4 | c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.91e-04 | 178 | 86 | 4 | 8151e5d73407fd9cba382b69a2bc707c81790c7f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.99e-04 | 179 | 86 | 4 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | COVID-19-kidney-Stressed_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.99e-04 | 179 | 86 | 4 | 754f69bac7a1d5137f5141f6193285ccbfe361cb | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.99e-04 | 179 | 86 | 4 | 8ce5000088b727783a0619baa16a2cd036d21f54 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.07e-04 | 180 | 86 | 4 | 9e09b3dfe344b5d50520711513d389865d73a861 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.07e-04 | 180 | 86 | 4 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| Drug | Moxonidine [75438-57-2]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 9.73e-06 | 199 | 85 | 7 | 7343_DN | |
| Drug | 4-chloro-6-methyl-pyrimidin-2-amine | 1.38e-05 | 2 | 85 | 2 | CID000021810 | |
| Drug | AC1L9KQO | 3.37e-05 | 49 | 85 | 4 | CID000447335 | |
| Drug | benzo-1,2,3-thiadiazole | 4.12e-05 | 3 | 85 | 2 | ctd:C015700 | |
| Drug | cis-diammineplatinum(II | 4.12e-05 | 3 | 85 | 2 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 4.12e-05 | 3 | 85 | 2 | CID002750949 | |
| Drug | 8N3-cADPR | 4.12e-05 | 3 | 85 | 2 | CID000127713 | |
| Drug | aminodantrolene | 4.12e-05 | 3 | 85 | 2 | CID009570289 | |
| Drug | AC1O3R1O | 4.12e-05 | 3 | 85 | 2 | CID006334720 | |
| Drug | 2-hydroxycarbazole | 4.12e-05 | 3 | 85 | 2 | CID000093551 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 4.12e-05 | 3 | 85 | 2 | CID005748312 | |
| Drug | Lt 2 | 4.61e-05 | 53 | 85 | 4 | CID003042936 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 2.28e-05 | 3 | 82 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 2.28e-05 | 3 | 82 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | Epilepsies, Partial | 2.28e-05 | 3 | 82 | 2 | C0014547 | |
| Disease | cholesteryl ester 14:0 measurement | 5.77e-05 | 27 | 82 | 3 | EFO_0010340 | |
| Disease | level of Phosphatidylinositol (18:1_18:2) in blood serum | 1.14e-04 | 6 | 82 | 2 | OBA_2045160 | |
| Disease | 1-arachidonoyl-GPI (20:4) measurement | 1.59e-04 | 7 | 82 | 2 | EFO_0800256 | |
| Disease | 1-linoleoyl-GPI (18:2) measurement | 1.59e-04 | 7 | 82 | 2 | EFO_0800266 | |
| Disease | 1-palmitoyl-2-linoleoyl-GPI (16:0/18:2) measurement | 1.59e-04 | 7 | 82 | 2 | EFO_0800609 | |
| Disease | Pena-Shokeir syndrome type I | 2.11e-04 | 8 | 82 | 2 | C1276035 | |
| Disease | Ciliopathies | 2.56e-04 | 110 | 82 | 4 | C4277690 | |
| Disease | 1-palmitoyl-2-arachidonoyl-GPI (16:0/20:4) measurement | 2.71e-04 | 9 | 82 | 2 | EFO_0800412 | |
| Disease | 1-stearoyl-2-oleoyl-GPI (18:0/18:1) measurement | 3.38e-04 | 10 | 82 | 2 | EFO_0800469 | |
| Disease | melanoma | 4.29e-04 | 126 | 82 | 4 | EFO_0000756 | |
| Disease | level of Phosphatidylinositol (18:0_20:3) in blood serum | 4.94e-04 | 12 | 82 | 2 | OBA_2045157 | |
| Disease | 1-stearoyl-2-linoleoyl-GPI (18:0/18:2) measurement | 5.83e-04 | 13 | 82 | 2 | EFO_0800413 | |
| Disease | prostate carcinoma (is_implicated_in) | 5.83e-04 | 13 | 82 | 2 | DOID:10286 (is_implicated_in) | |
| Disease | 1-stearoyl-2-dihomo-linolenoyl-GPI (18:0/20:3n3 or 6) measurement | 6.79e-04 | 14 | 82 | 2 | EFO_0022085 | |
| Disease | diacylglycerol 38:4 measurement | 6.79e-04 | 14 | 82 | 2 | EFO_0020066 | |
| Disease | eating disorder, bipolar disorder | 6.79e-04 | 14 | 82 | 2 | EFO_0005203, MONDO_0004985 | |
| Disease | phosphatidate measurement | 7.82e-04 | 15 | 82 | 2 | EFO_0020047 | |
| Disease | 1-stearoyl-2-arachidonoyl-GPI (18:0/20:4) measurement | 8.93e-04 | 16 | 82 | 2 | EFO_0800184 | |
| Disease | spine bone size | 1.13e-03 | 18 | 82 | 2 | EFO_0004508 | |
| Disease | diacylglycerol 38:3 measurement | 1.27e-03 | 19 | 82 | 2 | EFO_0020065 | |
| Disease | level of Phosphatidylinositol (18:0_18:2) in blood serum | 1.55e-03 | 21 | 82 | 2 | OBA_2045156 | |
| Disease | anxiety disorder (implicated_via_orthology) | 1.70e-03 | 22 | 82 | 2 | DOID:2030 (implicated_via_orthology) | |
| Disease | hip bone mineral density, fat body mass | 1.70e-03 | 22 | 82 | 2 | EFO_0005409, EFO_0007702 | |
| Disease | Renal glomerular disease | 1.86e-03 | 23 | 82 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 1.86e-03 | 23 | 82 | 2 | C4521256 | |
| Disease | level of Phosphatidylinositol (18:0_20:4) in blood serum | 1.86e-03 | 23 | 82 | 2 | OBA_2045158 | |
| Disease | Adenocarcinoma of large intestine | 2.45e-03 | 96 | 82 | 3 | C1319315 | |
| Disease | phosphatidylcholine 38:4 measurement | 2.75e-03 | 28 | 82 | 2 | EFO_0010386 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YEMMCGRLPFYNQDH | 341 | P31751 | |
| MYSEMIFVNGFVHCD | 301 | Q86TW2 | |
| AQIYMRFMQEHTCYD | 181 | Q9UGI9 | |
| ILHFFHQYMMACNYF | 221 | P30988 | |
| FLIVGAYMTHVCFNM | 11 | P49863 | |
| LYVFMVYFILHNQMC | 6146 | Q8WXG9 | |
| EYGDMQLICEAYHLM | 191 | P52209 | |
| ECLDYYGMLSLHRMF | 16 | Q8WXF8 | |
| HFQSYIMADMYSFGL | 391 | O00238 | |
| AFYLVFEYMDHDLMG | 786 | Q14004 | |
| GPAKNLMTMCFTYYH | 176 | O60268 | |
| SHVCVMLTFYMPAFF | 241 | Q8NGJ3 | |
| ECHMLAAMAYDGYVA | 146 | Q8NG78 | |
| YHFYCDMPAVMRLAC | 176 | Q8NGI7 | |
| FVMEYLNGGDLMYHI | 456 | Q04759 | |
| LMMLAAAIYGCTYAA | 301 | Q9HBL6 | |
| MAYTDTGMIYFIDHN | 301 | Q5TCQ9 | |
| VTDILCHMMPFYSYD | 341 | Q16706 | |
| YDTFHTVADMMYFCQ | 181 | Q9P035 | |
| VGGYMFNHSDYNMVL | 356 | O75882 | |
| QTMMHYFCALNTLQY | 176 | Q9UKG1 | |
| VLEMFDHAYGNYMEH | 56 | Q9BZQ6 | |
| HFLEAICCFPMVYYM | 826 | Q5JUK3 | |
| ILYEMCCMNHAFAGS | 221 | Q8NG66 | |
| AYDYMCMGFVLLSLA | 406 | Q96N66 | |
| GCLTQMYAFHLFGTM | 96 | O60431 | |
| MSFDRYMAICDPLHY | 116 | Q8NGM8 | |
| MYFADNILYTIHMGC | 371 | Q9H5V7 | |
| HMYHLLCLVAMYSNG | 446 | Q86Y01 | |
| NRGEDYVMTMPYAHC | 561 | Q9BZF1 | |
| EMAYCQHIGVEFMFI | 211 | Q02218 | |
| EHLQQYSYSCMGGML | 616 | O00471 | |
| GYNCIQLMAIMEHAY | 231 | Q04446 | |
| QLMAIMEHAYYASFG | 236 | Q04446 | |
| YSLMRESGYMHIQCT | 291 | P07099 | |
| IYGMYFCMNISSQGD | 161 | P29372 | |
| VSMTMQGFLNYYDAC | 191 | P35475 | |
| STDIFCHMMPFYSYD | 341 | P49641 | |
| QNLYCSRFMSHFNMY | 266 | P33032 | |
| MHLNAEGMLSYCDRY | 241 | Q9Y2S2 | |
| LGTPYMCFHQHLMYM | 271 | O95620 | |
| LMDGYCMFNHVAVAA | 221 | Q9UBN7 | |
| IMHSMAMFGREFCYA | 36 | Q9UMX9 | |
| FLYMAYADIMAKSCH | 3686 | Q92736 | |
| CDDMLTCYMFHMYVG | 4806 | Q92736 | |
| QFIHLYLMGCNYFWM | 216 | Q16602 | |
| MLTVMAYDRYVAICH | 131 | Q8NGG7 | |
| HCMDYLMKNADYFSN | 246 | Q96G74 | |
| TFMVMAYDRYVAICH | 121 | Q8NGH5 | |
| CSFHMIVVTMYYGPF | 241 | Q8NGZ0 | |
| CFEYFTDMMPLLHNY | 686 | O15397 | |
| NCFLLTVMGYDHYMA | 111 | Q8NGY7 | |
| TVMGYDHYMAICNPL | 116 | Q8NGY7 | |
| HSFLLAAMGYDRYMA | 111 | Q8NGX5 | |
| CFDMLQMDSRIAGYY | 186 | Q9UNW8 | |
| ECHMLAAMAYDCYVA | 111 | P0DMU2 | |
| MVRDGVYFMYEALHG | 231 | Q8N142 | |
| YEHHSYMGMRGFCAF | 136 | Q9UKY4 | |
| KRMCETMGYFFHAVY | 326 | Q7Z494 | |
| ILANTFYREHFGMYM | 291 | Q9H3E2 | |
| MFNLAYMYEHGLGIT | 591 | Q5TEA6 | |
| HSSFSMYCMLFVALY | 171 | O14494 | |
| PAHAMYFACYENMKR | 116 | Q9NYZ2 | |
| ADYGLEHLAYRMNMC | 106 | Q99707 | |
| MDACYGIHVYGMIND | 226 | Q8NDV1 | |
| PLHYFDSQCMAAMNF | 371 | Q9UNP4 | |
| HLACSDTFLNDMGMY | 186 | O14581 | |
| FYHCVNMTTGNMFDI | 1361 | Q9NY46 | |
| MFMAQISHCYPEYLS | 61 | Q9NVU7 | |
| YLVLEMCHNGEMNRY | 86 | O00444 | |
| YMDVMLENYCHLISV | 31 | Q8N184 | |
| TYCMYHFDLGYVQGM | 406 | Q9HA65 | |
| HMYCGSYMDHQTIFR | 436 | Q7RTY8 | |
| DMMTCYLFHMYVGVR | 4711 | Q15413 | |
| MEQYYHLVDMELNCT | 241 | P05543 | |
| CHYGLINYYQTMSMV | 436 | P55017 | |
| MILMTNHFYAAILGY | 201 | Q9NVA1 | |
| QLTELIHCMMYHYSG | 376 | Q8NB14 | |
| IADFGFARYLHSNMM | 156 | Q8IYT8 | |
| GVILVICYFMMHYVD | 166 | Q6NXT6 | |
| MLENYCHFVSVGFHM | 36 | Q96SR6 | |
| VFPAYMAYMICQFFH | 391 | Q96MT1 | |
| ALMFMYYTEPSGCHE | 221 | Q96SA4 | |
| SAIYNMCHLMEDRAY | 271 | P49815 | |
| MCTKMEQPFYHDDSY | 1 | P17275 | |
| HFALLNAYTYMMGAC | 1291 | Q8IZF0 | |
| YYDGCAMIAMNGSVF | 241 | Q6IA69 | |
| MCLLFEYMAYGDLNE | 651 | O15146 | |
| NYHVFYCMLEGMSED | 251 | Q13402 | |
| NYHIFYCMLMGVSAE | 251 | Q6PIF6 |